SciClone Pharmaceuticals (Holdings) Limited approved a final dividend of HKD 0.39 per ordinary share for the year ended December 31, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.72 HKD | +0.86% |
|
+0.86% | +34.48% |
06-26 | SciClone Pharmaceuticals Limited Announces Retirement of Wang Haixia as Non-Executive Director | CI |
06-21 | SciClone Pharmaceuticals Limited(SEHK:6600) dropped from S&P Global BMI Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.48% | 1.46B | |
+1.90% | 94.22B | |
-4.08% | 37.76B | |
-13.26% | 32.5B | |
+73.38% | 27.75B | |
-11.58% | 16.13B | |
-1.66% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- 6600 Stock
- News SciClone Pharmaceuticals (Holdings) Limited
- SciClone Pharmaceuticals Limited Approves a Final Dividend for the Year Ended December 31, 2022